Catalyst Wire Dossier Catalyst Wire Dossier

Topical formulation containing Ciplukan (Physalis angulata Linn.)

Physalis angulata extract topical formulation · Universitas Padjadjaran
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Topical formulation containing Ciplukan (Physalis angulata Linn.), covering 2025-04-01 to 2025-04-01. Get the full timeline:

Most recent: Clinical Trial Update: The Efficacy of Topical Formulation Containing Ciplukan (Physalis Angulata Linn.) on Psoriasis Vulgaris Lesions [Phase 1, Phase 2]

See pricing